Aurinia Pharmaceuticals Inc.

NasdaqGM:AUPH Stock Report

Mkt Cap: US$1.3b

Aurinia Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

2.7yrs

Average management tenure


CEO

Peter Greenleaf (52 yo)

3.75yrs

Tenure

US$1,240,389

Compensation

Mr. Peter S. Greenleaf, M.B.A., serves as Director at ValenzaBio, Inc. since August 2022. He has been President, Chief Executive Officer and Director of Aurinia Pharmaceuticals Inc. since April 29, 2019. M...


CEO Compensation Analysis

How has Peter Greenleaf's remuneration changed compared to Aurinia Pharmaceuticals's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$115m

Jun 30 2022n/an/a

-US$157m

Mar 31 2022n/an/a

-US$168m

Dec 31 2021US$1mUS$724k

-US$181m

Sep 30 2021n/an/a

-US$156m

Jun 30 2021n/an/a

-US$148m

Mar 31 2021n/an/a

-US$127m

Dec 31 2020US$11mUS$673k

-US$103m

Sep 30 2020n/an/a

-US$129m

Jun 30 2020n/an/a

-US$110m

Mar 31 2020n/an/a

-US$102m

Dec 31 2019US$5mUS$438k

-US$88m

Compensation vs Market: Peter's total compensation ($USD1.24M) is below average for companies of similar size in the US market ($USD5.39M).

Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Peter Greenleaf
President3.75yrsUS$1.24m0.023%
$ 303.6k
Joseph Miller
Chief Financial Officer2.75yrsUS$710.03k0.0046%
$ 60.9k
Matthew Donley
Executive Vice President of Operations & Strategyno dataUS$730.21k0.020%
$ 257.2k
Stephen Robertson
Executive VP2.17yrsUS$722.40k0.0082%
$ 107.6k
DeDe Sheel
Vice President of Investor Relation0.50yrno datano data
Chris Hays
Vice President of Marketing2.92yrsno datano data
Fran Lynch
Vice President of Sales2.92yrsno datano data
Michael Martin
Chief Business Officer2.58yrsUS$702.00k0.063%
$ 824.4k
Sue Evans
Head of Regulatory Affairs5yrsno datano data
Scott Habig
Chief Commercial Officer0.50yrno data0.0035%
$ 46.1k
Volker Knappertz
Executive Vice President of Research & Development0.50yrno datano data
Dana Lynch
Director of Corporate Communicationsno datano datano data

2.7yrs

Average Tenure

51yo

Average Age

Experienced Management: AUPH's management team is considered experienced (2.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Peter Greenleaf
President3.75yrsUS$1.24m0.023%
$ 303.6k
George Milne
Independent Chairman of the Board5.67yrsUS$289.80k0.035%
$ 460.4k
R. Mackay-Dunn
Independent Director3.58yrsUS$259.38k0.0077%
$ 101.3k
Joseph Hagan
Independent Director4.92yrsUS$266.88k0.0025%
$ 32.2k
Jill Leversage
Independent Director3.17yrsUS$260.84k0.0050%
$ 65.4k
Daniel Billen
Director3.75yrsUS$246.67k0.014%
$ 184.2k
David R. Jayne
Independent Non-Executive Director7.67yrsUS$251.67k0.021%
$ 276.3k
Brinda Balakrishnan
Independent Director1.58yrsUS$364.75k0%
$ 0

3.8yrs

Average Tenure

65.5yo

Average Age

Experienced Board: AUPH's board of directors are considered experienced (3.8 years average tenure).